Sheena Mukkada

Sheena Mukkada

Auto-generated profile, based on publicly available information

Sheena Mukkada

Department of Global Pediatric Medicine St. Jude Children's Research Hospital Memphis Tennessee USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2021 in The Lancet Oncology
Verified
Journal Article
Closed access
SMSheena Mukkada
Sheena Mukkada
NBNickhill Bhakta
Nickhill Bhakta
GCGuillermo L Chantada
Guillermo L Chantada
YCYichen Chen
Yichen Chen
YVYuvanesh Vedaraju
Yuvanesh Vedaraju
YSYumna Syed
Yumna Syed

12 September 2017 in Pediatric Blood & Cancer
Verified
Journal Article
Open access
PDF file
SMSheena Mukkada
Sheena Mukkada
CSCristel Kate Smith
Cristel Kate Smith
DADelta Aguilar
Delta Aguilar
ASApril Sykes
April Sykes
LTLi Tang
Li Tang
MCMiguela A. Caniza
Miguela A. Caniza
Background: In low‐ and middle‐income countries (LMICs), inconsistent or delayed management of fever contributes to poor outcomes among pediatric patients with cancer. We hypothesized that standardizing practice with a clinical algorithm adapted to local resources would improve outcomes. Therefore, we developed a resource‐specific algorithm for fever management in Davao City, Philippines. The primary objective of this study was to evaluate adherence to the algorithm.Procedure: This was a prospective cohort study of algorithm adherence to assess the types of deviation, reasons for deviation, and pathogens isolated. All pediatric oncology patients who were admitted with fever (defined as an axillary temperature >37.7°C on one occasion or ≥37.4°C on two occasions 1 hr apart) or who developed fever within 48 hr of admission were included. Univariate and multiple linear regression analyses were used to determine the relation between clinical predictors and length of hospitalization.Results: During the study, 93 patients had 141 qualifying febrile episodes. Even though the algorithm was designed locally, deviations occurred in 70 (50%) of 141 febrile episodes on day 0, reflecting implementation barriers at the patient, provider, and institutional levels. There were 259 deviations during the first 7 days of admission in 92 (65%) of 141 patient episodes. Failure to identify high‐risk patients, missed antimicrobial doses, and pathogen isolation were associated with prolonged hospitalization.Conclusions: Monitoring algorithm adherence helps in assessing the quality of pediatric oncology care in LMICs and identifying opportunities for improvement. Measures that decrease high‐frequency/high‐impact algorithm deviations may shorten hospitalizations and improve healthcare use in LMICs.

5 August 2022 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
Abdelhafeez AbdelhafeezAbdelhafeez Abdelhafeez
Abdelhafeez Abdelhafeez
TRTea Reljic
Tea Reljic
AKAmbuj Kumar
Ambuj Kumar
TBTahmina Banu
Tahmina Banu
SCSharon Cox
Sharon Cox
SASimone Abib
Simone Abib

17 November 2022 in Frontiers in Public Health
Verified
Journal Article
Open access
SMSheena Mukkada
Sheena Mukkada
MMMario Melgar
Mario Melgar
CBCraig Bullington
Craig Bullington
ACAlicia Chang
Alicia Chang
MHMaysam R. Homsi
Maysam R. Homsi
MCMiguela A. Caniza
Miguela A. Caniza
Infectious complications remain major contributors to adverse outcomes in patients treated for non-communicable disease, particularly in resource limited settings. We performed a 5-year retrospective study of primary bloodstream infections at a dedicated pediatric oncology center in Guatemala. Two hundred and twelve episodes occurring in 194 unique patients qualified for inclusion. Patients required intensive care unit admission in 55% of episodes and death occurred in 24% of episodes. Despite subspecialty support in infectious diseases, poor outcomes, including prolonged hospitalization and mortality, were frequent. Our findings suggest that investments in laboratory and clinical data collection are critical to understanding the contributors to poor outcomes and therefore to improving the quality of bloodstream infection management in resource limited settings.

1 January 2020 in JCO Global Oncology
Verified
Journal Article
Open access
MMMario Melgar
Mario Melgar
TRTea Reljic
Tea Reljic
GBGuillermo Barahona
Guillermo Barahona
KCKattia Camacho
Kattia Camacho
ACAlicia Chang
Alicia Chang
SMSheena Mukkada
Sheena Mukkada
PURPOSEOur objective was to provide regionally appropriate, resource-conscious recommendations for the diagnosis and treatment of pediatric patients with febrile neutropenia.METHODSA multinational panel of Central American and Caribbean clinicians who deliver pediatric oncology care prioritized clinically important questions and then used the Grading of Recommendations Assessment, Development and Evaluation methodology to provide recommendations on the selected topics.RESULTSTwenty-two questions and 2 definitions were included in the guideline, which was intended to establish minimum care standards for pediatric patients treated in regional centers. Of all the included studies, 6.9% were conducted in low- and middle-income countries, and no studies were performed in countries represented on the panel.CONCLUSIONThe panel made recommendations on the basis of existing evidence but identified important gaps in knowledge from the region and from resource-limited settings that may affect the clinical applicability of these recommendations. These deficiencies suggest a research agenda that will enable future guidelines to be more responsive to the local context. (c) 2020 by American Society of Clinical Oncology

24 February 2021 in Pediatric Blood & Cancer
Verified
Journal Article
Open access
PDF file
DMDaniel C. Moreira
Daniel C. Moreira
ESElizabeth Sniderman
Elizabeth Sniderman
SMSheena Mukkada
Sheena Mukkada
GCGuillermo L Chantada
Guillermo L Chantada
NBNickhill Bhakta
Nickhill Bhakta
CRCarlos Rodriguez‐Galindo
Carlos Rodriguez‐Galindo
The COVID‐19 pandemic quickly led to an abundance of publications and recommendations, despite a paucity of information on how COVID‐19 affects children with cancer. This created a dire need for a trusted resource with curated information and a space for the pediatric oncology community to share experiences. The Global COVID‐19 Observatory and Resource Center for Childhood Cancer was developed, launched, and maintained by the International Society of Pediatric Oncology and St. Jude Children's Research Hospital. The three components (Resource Library, Global Registry, and Collaboration Space) complement each other, establishing a mechanism to generate and transfer knowledge rapidly throughout the community.